Biblio

Author Title Type [ Year

]

Filters: Author is DiNardo, Courtney [Clear All Filters]

2019

Sasaki, K., Kantarjian, H.M., Kadia, T., Patel, K., Loghavi, S., Garcia-Manero, G., Jabbour, E.J., DiNardo, C., Pemmaraju, N., Daver, N., et al. (2019). Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemia.Cancer.

2016

Matre, P., Velez, J., Jacamo, R., Qi, Y., Su, X., Cai, T., Chan, S.M., Lodi, A., Sweeney, S.R., Ma, H., et al. (2016). Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes.Oncotarget.

2015

Takahashi, K., Kantarjian, H., Garcia-Manero, G., Borthakur, G., Kadia, T., DiNardo, C., Jabbour, E., Pierce, S., Estrov, Z., Konopleva, M., et al. (2015). Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.Clin Lymphoma Myeloma Leuk.